OR WAIT null SECS
Click here to read the articles and view the interactive digital edition
Despite the ongoing turmoil over tariffs, medicine costs, and FDA policy, US wholesalers are performing well.
From rethinking launch price logic to implementing rebate-aware modeling and patient-first access programs, this installment explores how disciplined governance and forward-thinking models can safeguard profitability in a volatile market.
As pharma drug pricing debates heat up, the 340B program faces mounting challenges from outdated regulations, duplicate discounts, and limited transparency.
May 21, 2025
Ruth Beadle, head, global supply chain, Sanofi, discusses how digital integration, advanced planning, and sustainability goals are transforming end-to-end supply chain operations to improve scale, speed, and environmental impact.
The telehealth site will welcome its own small-dose, compounded version of semaglutide, which mimics the function of a GLP-1.
May 20, 2025
An NEJM study explores how this loss—following Medicaid disenrollment—affects beneficiaries.
In the third part of his Pharma Commerce video interview, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, dives into the barriers limiting AI and automation’s widespread adoption in R&D.
May 19, 2025
The partnership is centered around cutting cold chain costs and emissions with smart packaging and carbon-neutral same-day delivery.
Ruth Beadle, head, global supply chain, Sanofi, discusses the company’s multi-year effort to build an AI-powered, end-to-end supply chain focused on improving service, resilience, and cost efficiency.
May 16, 2025
In an exclusive sit-down with Pharma Commerce, Anne Cassity, senior vice president of government affairs for the National Community Pharmacists Association (NCPA), discusses pending legislation that could affect the impact of PBM pricing.